C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions TELO Q4 2025 Earnings WiderthanExpected Loss Stings as PreRevenue Biotech Focuses on Pipeline Comstock Resources Q1 2026 Earnings EPS Misses Estimates as Company Reports Disappointing Quarter Nasdaq Inc Q1 2026 Earnings EPS Slightly Exceeds Street Estimates Amid Steady Performance APYX Q1 2026 Earnings A NarrowerThanExpected Loss Led by Cost Discipline